Article continues below It also boasts the Wild West-themed Frontier Falls, and the newest Viking zone where there are big rollercoasters for thrillseekers like Accelerator, as well as the popular ...

A second analyst voices positive thoughts on Viking's new GLP-1 weight loss drug. Phase 3 clinical trial data on VK2735 arrives later this year, and phase 2 data on a GLP-1 pill could come out as ...

That's what investors are hoping for from Viking Therapeutics (NASDAQ: VKTX), a young company seeking to establish itself in this highly competitive industry. Viking stock has been extraordinarily ...

The accelerator is open to Seed to Series A startups based in Africa, building AI-first solutions. Startups must have a live product, at least one founder of African descent, and a clear vision ...

THORWallet, the mobile-first DeFi superapp, is now part of the Cointelegraph Accelerator. This move supports its mission to bring secure, self-custodial tools to everyday users and institutions ...

Not even the helmet? Okay. To find out a bit more about who the Vikings actually were, I've come to the Museum of South Australia to see a real Viking hoard and meet a real Viking expert.

Penang, Malaysia -- April 30, 2025 – SkyeChip Berhad, a Malaysian integrated circuit (IC) design company specialising in high-performance silicon IP, today announced its participation in the Intel ...

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is preparing for the possible FDA approval of its weight loss drug candidate ...

Now, let's consider Viking's situation. The biotech also is working on an oral weight loss treatment and recently fully enrolled its phase 2 trial. Viking said enrollment was "rapid," signaling a ...